Cargando…
LAG-3: from molecular functions to clinical applications
To prevent the destruction of tissues owing to excessive and/or inappropriate immune responses, immune cells are under strict check by various regulatory mechanisms at multiple points. Inhibitory coreceptors, including programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4), ser...
Autores principales: | Maruhashi, Takumi, Sugiura, Daisuke, Okazaki, Il-mi, Okazaki, Taku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488795/ https://www.ncbi.nlm.nih.gov/pubmed/32929051 http://dx.doi.org/10.1136/jitc-2020-001014 |
Ejemplares similares
-
PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation
por: Mizuno, Reina, et al.
Publicado: (2019) -
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
por: Okazaki, Taku, et al.
Publicado: (2011) -
Days weaving the lagging strand synthesis of DNA — A personal recollection of the discovery of Okazaki fragments and studies on discontinuous replication mechanism —
por: OKAZAKI, Tsuneko
Publicado: (2017) -
Clinical landscape of LAG-3-targeted therapy
por: Chocarro, L., et al.
Publicado: (2022) -
Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications
por: Zhao, Lishu, et al.
Publicado: (2022)